Unique ID issued by UMIN | UMIN000055000 |
---|---|
Receipt number | R000062837 |
Scientific Title | Comprehensive Analysis of Factors Improving Premenstrual Syndrome by Intake of Oligonol (low molecular weight polyphenol) - Double-blind, placebo-controlled RCT study in young women |
Date of disclosure of the study information | 2024/07/17 |
Last modified on | 2024/07/17 18:38:01 |
Comprehensive Analysis of Factors Improving Premenstrual Syndrome by Intake of Oligonol (low molecular weight polyphenol) - Double-blind, placebo-controlled RCT study in young women
Comprehensive Analysis of Factors Improving Premenstrual Syndrome by Intake of Oligonol (low molecular weight polyphenol) - Double-blind, placebo-controlled RCT study in young women
Comprehensive Analysis of Factors Improving Premenstrual Syndrome by Intake of Oligonol (low molecular weight polyphenol) - Double-blind, placebo-controlled RCT study in young women
Comprehensive Analysis of Factors Improving Premenstrual Syndrome by Intake of Oligonol (low molecular weight polyphenol) - Double-blind, placebo-controlled RCT study in young women
Japan |
premenstrual syndrome(PMS)
Obstetrics and Gynecology | Psychiatry | Adult |
Others
NO
The purpose of this study is to comprehensively analyze factors related to menstrual symptoms caused by the intake of Oligonol (low molecular weight polyphenol) by metabolomic analysis, and to elucidate the mechanism of improvement of menstrual symptoms by Oligonol, which has strong antioxidant effects.
Efficacy
Subjects will be asked to take the sample once a day for 8 weeks, one capsule (200 mg per capsule) before sleep. The sample will be taken starting on the 21st day after the start of the last menstrual period (day 0) and will be taken until the 21st day after the start of menstruation 2 months later (day 56). Urine samples will be sent to Human Metabolome Technologies, Inc. for metabolomics analysis using a cohort study pack (CE-FTMS).
Interventional
Parallel
Randomized
Individual
Double blind -all involved are blinded
Placebo
2
Prevention
Food |
Subjects will be asked to take the sample once a day for 8 weeks, one capsule (200 mg per capsule) before sleep. The sample will be taken starting on the 21st day after the start of the last menstrual period (day 0) and will be taken until the 21st day after the start of menstruation 2 months later (day 56).
Test sample: (1) Oligonol: 1 capsule (200 mg) (2) Placebo (dextrin): 1 capsule (200 mg)
20 | years-old | <= |
25 | years-old | > |
Female
Normal menstruation
Menstrual irregularities, pill users, and users of antioxidant supplements different from those in this study
20
1st name | Masaki |
Middle name | |
Last name | Taga |
Wayo Women's University
Department of Health and Nutrition, Faculty of Home Economics
2728533
2-3-1 Konodai, Ichikawa-shi, Chiba
047-371-1591
m-taga@wayo.ac.jp
1st name | Masaki |
Middle name | |
Last name | Taga |
Wayo Women's University
Department of Health and Nutrition, Faculty of Home Economics
2728533
2-3-1 Konodai, Ichikawa-shi, Chiba
047-371-1591
m-taga@wayo.ac.jp
Wayo Women's University
Amino Up Corp
Other
Wayo Women's University
2-3-1 Konodai, Ichikawa-shi, Chiba
047-371-1591
m-taga@wayo.ac.jp
NO
2024 | Year | 07 | Month | 17 | Day |
Unpublished
20
No longer recruiting
2024 | Year | 05 | Month | 18 | Day |
2024 | Year | 06 | Month | 13 | Day |
2024 | Year | 06 | Month | 13 | Day |
2024 | Year | 08 | Month | 08 | Day |
2024 | Year | 07 | Month | 17 | Day |
2024 | Year | 07 | Month | 17 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000062837
Research Plan | |
---|---|
Registered date | File name |
Research case data specifications | |
---|---|
Registered date | File name |
Research case data | |
---|---|
Registered date | File name |